MicroRNA-182 promoted esophageal squamous cell carcinoma cell growth and metastasis via targeting YWHAG

被引:1
作者
Bai, Qizhou [1 ]
Yu, Jun [1 ]
Li, Yongshun [1 ]
Ma, Jilong [1 ]
Gou, Yunjiu [1 ]
机构
[1] Gansu Prov Peoples Hosp, Dept Thorac Surg, 204 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China
来源
JOURNAL OF BUON | 2018年 / 23卷 / 05期
关键词
esophageal squamous cell carcinoma; metastasis; miR-182; proliferation; YWHAG; CANCER; EXPRESSION; BIOMARKERS; INVASION; PROLIFERATION; MIR-182; RELEVANCE; APOPTOSIS; FEATURES; OUTCOMES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study the functioning mode of miR-182 on esophageal squamous cell carcinoma (ESCC) cell growth and metastasis and provide therapeutic targets for ESCC. Methods: miR-182 expression level in ESCC cell lines was examined by quantitative real-time polymerase chain reaction (qRT-PCR). Using miR-182 inhibitor, we analyzed the effects of miR-182 down-expression on cell proliferation, invasion, cell apoptosis and cell cycle. Dual-luciferase activity assay was used to examine the potential target gene YWHAG which was predicted by several databases. Protein level was studied using western blotting. Results: Decreased expression of miR-182 in ESCC cells was accompanied by decreased cell invasion and proliferation, promotion of cell apoptosis and cell cycle arrest at GO/GI phase. Dual-luciferase and western blot confirmed YWHAG as a target gene of miR-182. Furthermore, silence of YWHAG counteracted the suppressive effect of miR-182 down-expression on cell growth and metastasis. Conclusions: miR-182 could suppress ESCC cell proliferation and metastasis via regulating YWHAG, which might provide a new target for ESCC diagnosis and therapy.
引用
收藏
页码:1439 / 1447
页数:9
相关论文
共 29 条
  • [1] MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
    Amaral, Fernando Colbari
    Torres, Natalia
    Saggioro, Fabiano
    Neder, Luciano
    Machado, Helio Rubens
    Silva, Wilson Araujo, Jr.
    Moreira, Ayrton Custodio
    Castro, Margaret
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) : 320 - 323
  • [2] Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma
    Chen, Lin
    Chu, Feihu
    Cao, Yali
    Shao, Jianguo
    Wang, Feng
    [J]. TUMOR BIOLOGY, 2015, 36 (10) : 7439 - 7447
  • [3] Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer
    Chen, Qingjuan
    Ge, Xiaojun
    Zhang, Yuchen
    Xia, Hongwei
    Yuan, Dandan
    Tang, Qiulin
    Chen, Liang
    Pang, Xiaohui
    Leng, Weibing
    Bi, Feng
    [J]. ONCOLOGY REPORTS, 2014, 31 (04) : 1863 - 1870
  • [4] Does Minimally Invasive Esophagectomy (MIE) Provide for Comparable Oncologic Outcomes to Open Techniques? A Systematic Review
    Dantoc, Marc M.
    Cox, Michael R.
    Eslick, Guy D.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (03) : 486 - 494
  • [5] Prospective impact of tumor grade assessment in biopsies on tumor stage and prognostic grouping in gastroesophageal adenocarcinoma Relevance of the Seventh Edition American Joint Committee on Cancer Staging Manual Revision
    Dikken, Johan L.
    Coit, Daniel G.
    Klimstra, David S.
    Rizk, Nabil P.
    van Grieken, Nicole
    Ilson, David
    Tang, Laura H.
    [J]. CANCER, 2012, 118 (02) : 349 - 357
  • [6] Fu JH, 2018, EUR REV MED PHARMACO, V22, P351, DOI 10.26355/eurrev_201801_14179
  • [7] Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in Japan
    Hosokawa, Yuichi
    Kinoshita, Takahiro
    Konishi, Masaru
    Takahashi, Shinichiro
    Gotohda, Naoto
    Kato, Yuichiro
    Daiko, Hiroyuki
    Nishimura, Mitsuyo
    Katsumata, Kenji
    Sugiyama, Yasuyuki
    Kinoshita, Taira
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) : 677 - 683
  • [8] The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma
    Jia, J.
    Cui, Y.
    Lu, M.
    Wang, X.
    Li, Jie
    Li, Jian
    Li, Y.
    Zhang, X.
    Gao, J.
    Zhou, J.
    Lu, Z.
    Gong, J.
    Yu, J.
    Sun, Z.
    Liu, C.
    Shen, L.
    Zhang, X.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (06) : 592 - 598
  • [9] Multiple management modalities in esophageal cancer: Epidemiology, presentation and progression, work-up, and surgical approaches
    Koshy, M
    Esiashvilli, N
    Landry, JC
    Thomas, CR
    Matthews, RH
    [J]. ONCOLOGIST, 2004, 9 (02) : 137 - 146
  • [10] Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma
    Li, Yi
    Guo, Hui
    Dong, Danfeng
    Wu, Huili
    Li, Enxiao
    [J]. DIAGNOSTIC PATHOLOGY, 2013, 8